President Trump signed an executive order to lower prescription drug prices in the US. The healthcare technology company Kalderos is working to simplify the complexities of the US drug system by working with manufacturers, healthcare providers and government agencies to ensure accurate pricing. Angie Franks, Kalderos CEO joined the C-Suite on Bloomberg Open Interest to talk about how her company is trying to make the US healthcare system more efficient.